Nymox Pharmaceutical Corp. diskutieren
Nymox Pharmaceutical Corp.
WKN: A144CA / Symbol: NYMX / Name: Nymox Pharmaceutical / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
0,23 €
5,41 %
Nymox buy
Intuition
(Vom Mitglied beendet)
(Laufzeit überschritten)
(Vom Mitglied beendet)
SecteurRecherche biotechnologique et médicale Agenda 15/11 Publication de résultats
Nymox Pharmaceutical Corp.operates as a biopharmaceutical company, which engages in the research and development on products for the aging population.
Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer.
It operates through the following geographical segments: Canada, United States, and Europe.
The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.
Nombre d'employés : 2 personnes.
(Zielkurs erreicht)
Sell mit Kursziel 1,8
Sell mit Kursziel 1,0
Sell Nymox Pharmaceutical Corp.
Buy mit Kursziel 3,0
Buy Nymox Pharmaceutical Corp.
Sell Nymox Pharmaceutical Corp.
Buy Nymox Pharmaceutical Corp.
Sell Nymox Pharmaceutical Corp.
Sell Nymox Pharmaceutical Corp.
Sell Nymox Pharmaceutical Corp.
Sell Nymox Pharmaceutical Corp.
Neueste Beiträge
OP_Research in The Hackett Group diskutieren